Status:
UNKNOWN
COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador
Lead Sponsor:
Hospital San Carlos, Madrid
Collaborating Sponsors:
Universidad Catolica Santiago de Guayaquil
Conditions:
COVID
Eligibility:
All Genders
18+ years
Brief Summary
In December 2019, an outbreak of pneumonia of initially unknown cause was detected in Wuhan (Hubei, China), and it was quickly determined that it was caused by a new coronavirus, that is, the SARS-CoV...
Detailed Description
Design: Retrospective cohort study that will review the data of patients seen in participating centers with a confirmed or probable diagnosis of COVID-19 between March and April 2020. Those patients w...
Eligibility Criteria
Inclusion
- Patients 18 years or older who required hospitalization.
- Confirmed diagnosis of COVID-19 by positive nasopharyngeal exudate for SARS-CoV-2.
- Probable diagnosis of COVID-19, according to WHO criteria.
Exclusion
- \- Patients with negative nasopharyngeal exudate for SARS-CoV-2.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04362969
Start Date
May 1 2020
End Date
May 1 2020
Last Update
May 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GastroMuñoz
Guayaquil, Guayas, Ecuador